51 related articles for article (PubMed ID: 24400437)
1. Scaffold evaluation of liguzinediol analogs as novel cardiotonic agents.
Liu Z; Li W; Qin K; Wen K; Zhu CJ; Li NG; Bian HM; Wen HM; Chen L
Pharmazie; 2013 Dec; 68(12):926-32. PubMed ID: 24400437
[TBL] [Abstract][Full Text] [Related]
2. The novel compound liguzinediol exerts positive inotropic effects in isolated rat heart via sarcoplasmic reticulum Ca2+ ATPase-dependent mechanism.
Chen L; Xu Y; Li W; Wu H; Luo Z; Li X; Huang F; Young C; Liu Z; Zhou S
Life Sci; 2012 Oct; 91(11-12):402-408. PubMed ID: 22906633
[TBL] [Abstract][Full Text] [Related]
3. Liguzinediol Enhances the Inotropic Effect of Rat Hearts via Inhibition of Protein Phosphatase (PP1 and PP2A) Activities.
Li S; Huang H; Zhang M; Wang W; Xue S; Gao Y; Xie M; Chen K; Liu F; Chen L
J Cardiovasc Pharmacol; 2017 Apr; 69(4):236-244. PubMed ID: 28134629
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of liguzinediol mono- and dual ester prodrugs as promising inotropic agents.
Zhang J; Li W; Wen HM; Zhu HH; Wang TL; Cheng D; Yang KD; Chen YQ
Molecules; 2014 Nov; 19(11):18057-72. PubMed ID: 25379643
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and positive inotropic activity evaluation of liguzinediol metabolites.
Zhu HH; Chen YQ; Cheng D; Li W; Wang TL; Wen HM; Chen L; Liu J
Bioorg Med Chem Lett; 2016 Feb; 26(3):882-884. PubMed ID: 26725025
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and pharmacokinetic study of novel liguzinediol prodrugs.
Liu Z; Li W; Wen HM; Bian HM; Zhang J; Chen L; Chen L; Yang KD
Molecules; 2013 Apr; 18(4):4561-72. PubMed ID: 23599014
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of cardiodepression by an Na+-H+ exchange inhibitor methyl-N-isobutyl amiloride (MIA) on the heart: lack of beneficial effects in ischemia-reperfusion injury.
Saini HK; Elimban V; Ozcelikay AT; Dhalla NS
Can J Physiol Pharmacol; 2007 Jan; 85(1):67-78. PubMed ID: 17487246
[TBL] [Abstract][Full Text] [Related]
8. Sulfotransferase-catalyzed biotransformation of liguzinediol and comparison of its metabolism in different species using UFLC-QTOF-MS.
Shen F; Wen HM; Shan CX; Kang A; Dong B; Chai C; Zhang JY; Zhang Q; Li W
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():1-7. PubMed ID: 29738966
[TBL] [Abstract][Full Text] [Related]
9. Reduced inotropic effect of nifekalant in failing hearts in rats.
Endo H; Miura M; Hirose M; Takahashi J; Nakano M; Wakayama Y; Sugai Y; Kagaya Y; Watanabe J; Shirato K; Shimokawa H
J Pharmacol Exp Ther; 2006 Sep; 318(3):1102-7. PubMed ID: 16738208
[TBL] [Abstract][Full Text] [Related]
10. Imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyrazines: the role of nitrogen position in inotropic activity.
Spitzer WA; Victor F; Pollock GD; Hayes JS
J Med Chem; 1988 Aug; 31(8):1590-5. PubMed ID: 3397997
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and positive inotropic activity of several 5-aminopyrido[2,3-d]pyrimidines. Part 5: Compounds with positive inotropic activity.
Heber D; Ravens U; Schulze T
Pharmazie; 1993 Jul; 48(7):509-13. PubMed ID: 8415847
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of new esters of 2- and 4-alkylamino-1,8-naphthyridine-3-carboxylic acids endowed with positive inotropic properties.
Heber D; Verborg M; Mohr K
Arzneimittelforschung; 1994 Jul; 44(7):809-14. PubMed ID: 7945513
[TBL] [Abstract][Full Text] [Related]
13. [Positive inotropic agents: modelling, synthesis and SAR].
Leclerc GA
J Pharm Belg; 1991; 46(1):23-36. PubMed ID: 2051299
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel ligustrazine derivatives as NA+/H+ exchange inhibitors.
Ren M; Dong J; Xu Y; Wen N; Gong G
Chem Biodivers; 2010 Nov; 7(11):2727-36. PubMed ID: 21072772
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Na+,K(+)-ATPase by flavonoids and their inotropic effect. Investigation of the structure-activity relationship.
Umarova FT; Khushbactova ZA; Batirov EH; Mekler VM
Membr Cell Biol; 1998; 12(1):27-40. PubMed ID: 9829256
[TBL] [Abstract][Full Text] [Related]
16. N-aralkyl substitution of 2-aminoindans. Synthesis and their inotropic and chronotropic activity in isolated guinea pig atria.
Pérez JA; Domínguez JN; Angel JE; Duerto de Pérez Z; Salazar-Bookaman MM; Acosta H; Charris JE
Arzneimittelforschung; 1997 Nov; 47(11):1208-10. PubMed ID: 9428975
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
[TBL] [Abstract][Full Text] [Related]
18. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and structure-activity relationship studies of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives as cardiotonic agents.
Wang T; Dong Y; Wang LC; Xiang BR; Chen Z; Qu LB
Arzneimittelforschung; 2008; 58(11):569-73. PubMed ID: 19137907
[TBL] [Abstract][Full Text] [Related]
20. [The positive inotropic effect after washout of acetylcholine in isolated rabbit hearts].
Luo HJ; Zhang FJ; Si JQ; Yang RR; Zhao L; Gao WJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 May; 24(2):197-200. PubMed ID: 21141525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
